NCT01417520
- Conditions
- Albinism, Albinism, Oculocutaneous, Amino Acid Metabolism, Inborn Errors, +50 more
- Locations
-
- National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
Clinical trial condition
Sphingolipidoses
Explore clinical trials studying Sphingolipidoses. Study availability and eligibility vary by location and protocol.
394 public trials
77 recruiting studies
Sphingolipidoses trial results
NCT00383448
- Conditions
- Adrenal Gland Diseases, Adrenal Insufficiency, Adrenoleukodystrophy, +55 more
- Locations
-
- Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States
NCT01358474
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Brain Diseases, Metabolic, +21 more
- Locations
-
- University of Minnesota, Center for Magnetic Resonance Research Minneapolis, Minnesota, United States
NCT01371825
- Conditions
- Alcohol-Induced Disorders, Alcohol-Related Disorders, Brain Diseases, +33 more
- Locations
-
- Irvine, California, United States
- Cairo, Egypt
- Grenoble, France
- Paris, France
NCT01196871
- Conditions
- Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
- Locations
-
- Birmingham, Alabama, United States
- Decatur, Georgia, United States
- Iowa City, Iowa, United States
- Kansas City, Kansas, United States
NCT01218659
- Conditions
- Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
- Locations
-
- Los Angeles, California, United States
- Aurora, Colorado, United States
- Decatur, Georgia, United States
- Grand Rapids, Michigan, United States
NCT00283959
- Conditions
- Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
- Locations
-
- Parkville, Australia
- Porto Alegre, Brazil
NCT00214500
- Conditions
- Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
- Locations
-
- Los Angeles, California, United States
- Decatur, Georgia, United States
- Bethesda, Maryland, United States
- New York, United States
Completed
Study of the Effects of Oral AT1001 (Migalastat Hydrochloride) in Patients With Fabry Disease
NCT00925301
- Conditions
- Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
- Locations
-
- Los Angeles, California, United States
- San Francisco, California, United States
- Decatur, Georgia, United States
- Chicago, Illinois, United States
Completed
Cardiac Involvement in Adult Patients With Fabry Disease; Relation to Enzyme Replacement Therapy
NCT02908724
- Conditions
- Aortic Stenosis, Subvalvular, Aortic Valve Disease, Aortic Valve Stenosis, +31 more
- Locations
-
Not specified